ascopubs.org5d
Circulating tumor DNA as a prognostic biomarker to predict retroperitoneal histology in patients undergoing retroperitoneal lymph node dissection.
Development of an miRNA signature for individual prognostic assessment in seminoma patients. Test characteristics of ctDNA stratified by primary or post-chemotherapy RPLND.
ascopubs.org5d
Reduction of systemic chemotherapy by primary retroperitoneal lymph node dissection in low volume metastatic seminoma.
Validation of new prognostic factors for relapse in patients with clinical stage I seminoma. Time to real-world progression (TTrwP) among patients (pts) with relapsed/refractory (R/R) testicular germ ...
Nature4y
Marijuana use linked with testicular cancer
Marijuana use was associated with a high incidence of non-seminoma or mixed-histology carcinoma. Regular marijuana users and/or those who had long-term exposure to the substance (beginning before ...
UroToday8d
ASCO GU 2025: Prospective COTRIMS (Cologne Trial of Retroperitoneal Lymphadenectomy in Metastatic Seminoma) Trial: Final Results
Dr. Axel Heidenreich presented the final results of the COTRIMS (Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma) trial. Clinical stage (CS) IIA/B seminoma accounts for only 10 ...